Skip to main content
21 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Why AstraZeneca is revisiting olaparib
Read more
Next steps for the EU Clinical Trials Directive
Read more
An analysis of accelerated approval for cancer drugs
Read more
Vaccine for Parkinson's disease enters the clinic for the first time
Read more
Reforming the EU Clinical Trials Directive
Read more
The outlook for new clinical trials legislation in Europe
Read more
How cannabis medicines gained legitimacy
Read more
Denmark has introduced new procedures for ADRs
Read more
Finding solutions to drug resistance
Read more
Analysis of Special Protocol Assessments for oncology
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Page
4
Page
5
Current page
6
Page
7
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form